Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data - PubMed (original) (raw)
Review
doi: 10.1136/bmj.i6583.
David A Jolliffe 3, Richard L Hooper 3, Lauren Greenberg 3, John F Aloia 4, Peter Bergman 5, Gal Dubnov-Raz 6, Susanna Esposito 7, Davaasambuu Ganmaa 8, Adit A Ginde 9, Emma C Goodall 10, Cameron C Grant 11, Christopher J Griffiths 3 2 12, Wim Janssens 13, Ilkka Laaksi 14, Semira Manaseki-Holland 15, David Mauger 16, David R Murdoch 17, Rachel Neale 18, Judy R Rees 19, Steve Simpson Jr 20, Iwona Stelmach 21, Geeta Trilok Kumar 22, Mitsuyoshi Urashima 23, Carlos A Camargo Jr 24
Affiliations
- PMID: 28202713
- PMCID: PMC5310969
- DOI: 10.1136/bmj.i6583
Review
Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data
Adrian R Martineau et al. BMJ. 2017.
Abstract
Objectives To assess the overall effect of vitamin D supplementation on risk of acute respiratory tract infection, and to identify factors modifying this effect.Design Systematic review and meta-analysis of individual participant data (IPD) from randomised controlled trials.Data sources Medline, Embase, the Cochrane Central Register of Controlled Trials, Web of Science, ClinicalTrials.gov, and the International Standard Randomised Controlled Trials Number registry from inception to December 2015.Eligibility criteria for study selection Randomised, double blind, placebo controlled trials of supplementation with vitamin D3 or vitamin D2 of any duration were eligible for inclusion if they had been approved by a research ethics committee and if data on incidence of acute respiratory tract infection were collected prospectively and prespecified as an efficacy outcome.Results 25 eligible randomised controlled trials (total 11 321 participants, aged 0 to 95 years) were identified. IPD were obtained for 10 933 (96.6%) participants. Vitamin D supplementation reduced the risk of acute respiratory tract infection among all participants (adjusted odds ratio 0.88, 95% confidence interval 0.81 to 0.96; P for heterogeneity <0.001). In subgroup analysis, protective effects were seen in those receiving daily or weekly vitamin D without additional bolus doses (adjusted odds ratio 0.81, 0.72 to 0.91) but not in those receiving one or more bolus doses (adjusted odds ratio 0.97, 0.86 to 1.10; P for interaction=0.05). Among those receiving daily or weekly vitamin D, protective effects were stronger in those with baseline 25-hydroxyvitamin D levels <25 nmol/L (adjusted odds ratio 0.30, 0.17 to 0.53) than in those with baseline 25-hydroxyvitamin D levels ≥25 nmol/L (adjusted odds ratio 0.75, 0.60 to 0.95; P for interaction=0.006). Vitamin D did not influence the proportion of participants experiencing at least one serious adverse event (adjusted odds ratio 0.98, 0.80 to 1.20, P=0.83). The body of evidence contributing to these analyses was assessed as being of high quality.Conclusions Vitamin D supplementation was safe and it protected against acute respiratory tract infection overall. Patients who were very vitamin D deficient and those not receiving bolus doses experienced the most benefit.Systematic review registration PROSPERO CRD42014013953.
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi\_disclosure.pdf and declare financial support for this work from the National Institute for Health Research under its Health Technology Assessment programme. No author has had any financial relationship with any organisations that might have an interest in the submitted work in the previous three years. No author has had any other relationship, or undertaken any activity, that could appear to have influenced the submitted work.
Figures
Fig 1 Flow of study selection. IPD=individual participant data
Fig 2 Two step individual participant data meta-analysis: proportion of participants experiencing at least one acute respiratory tract infection (ARTI). Data from trial by Simpson et al
were not included in this two step meta-analysis, as an estimate for the effect of the intervention in the study could not be obtained in the regression model owing to small sample size
Comment in
- Making uncertainty work.
Cook S. Cook S. BMJ. 2017 Feb 16;356:j815. doi: 10.1136/bmj.j815. BMJ. 2017. PMID: 28209588 No abstract available. - Review: In children and adults, vitamin D3 supplementation reduces risk for acute respiratory tract infection.
Sacks HS. Sacks HS. Ann Intern Med. 2017 May 16;166(10):JC51. doi: 10.7326/ACPJC-2017-166-10-051. Ann Intern Med. 2017. PMID: 28505635 No abstract available. - Vitamin D reduces respiratory tract infections frequency.
Bhutta ZA. Bhutta ZA. J Pediatr. 2017 Jul;186:209-212. doi: 10.1016/j.jpeds.2017.04.021. J Pediatr. 2017. PMID: 28648275 No abstract available. - Weniger akute Atemwegsinfekte durch Vitamin-D-Supplementation?
Weckbecker K. Weckbecker K. Laryngorhinootologie. 2018 Aug;97(8):524-525. doi: 10.1055/a-0648-6964. Epub 2018 Aug 6. Laryngorhinootologie. 2018. PMID: 30081412 German. - PURL: Can vitamin D prevent acute respiratory infections?
Marshall B, Bennett N, Smith A, Oh R, Burket J. Marshall B, et al. J Fam Pract. 2019 May;68(4):230-231. J Fam Pract. 2019. PMID: 31226177 Free PMC article. - Vitamin D deficiency and the COVID-19 pandemic.
Zemb P, Bergman P, Camargo CA Jr, Cavalier E, Cormier C, Courbebaisse M, Hollis B, Joulia F, Minisola S, Pilz S, Pludowski P, Schmitt F, Zdrenghea M, Souberbielle JC. Zemb P, et al. J Glob Antimicrob Resist. 2020 Sep;22:133-134. doi: 10.1016/j.jgar.2020.05.006. Epub 2020 May 29. J Glob Antimicrob Resist. 2020. PMID: 32474141 Free PMC article. - Facing COVID-19 and Refugee Camps on the U.S. Border.
Leiner A, Sammon M, Perry H, Dunavant S. Leiner A, et al. J Emerg Med. 2020 Jul;59(1):143-145. doi: 10.1016/j.jemermed.2020.04.041. J Emerg Med. 2020. PMID: 32900460 Free PMC article. No abstract available.
Similar articles
- Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis.
Martineau AR, Jolliffe DA, Greenberg L, Aloia JF, Bergman P, Dubnov-Raz G, Esposito S, Ganmaa D, Ginde AA, Goodall EC, Grant CC, Janssens W, Jensen ME, Kerley CP, Laaksi I, Manaseki-Holland S, Mauger D, Murdoch DR, Neale R, Rees JR, Simpson S, Stelmach I, Trilok Kumar G, Urashima M, Camargo CA, Griffiths CJ, Hooper RL. Martineau AR, et al. Health Technol Assess. 2019 Jan;23(2):1-44. doi: 10.3310/hta23020. Health Technol Assess. 2019. PMID: 30675873 Free PMC article. - Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials.
Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, Bergman P, Bischoff-Ferrari HA, Borzutzky A, Damsgaard CT, Dubnov-Raz G, Esposito S, Gilham C, Ginde AA, Golan-Tripto I, Goodall EC, Grant CC, Griffiths CJ, Hibbs AM, Janssens W, Khadilkar AV, Laaksi I, Lee MT, Loeb M, Maguire JL, Majak P, Mauger DT, Manaseki-Holland S, Murdoch DR, Nakashima A, Neale RE, Pham H, Rake C, Rees JR, Rosendahl J, Scragg R, Shah D, Shimizu Y, Simpson-Yap S, Trilok-Kumar G, Urashima M, Martineau AR. Jolliffe DA, et al. Lancet Diabetes Endocrinol. 2021 May;9(5):276-292. doi: 10.1016/S2213-8587(21)00051-6. Epub 2021 Mar 30. Lancet Diabetes Endocrinol. 2021. PMID: 33798465 - Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data.
Jolliffe DA, Greenberg L, Hooper RL, Griffiths CJ, Camargo CA Jr, Kerley CP, Jensen ME, Mauger D, Stelmach I, Urashima M, Martineau AR. Jolliffe DA, et al. Lancet Respir Med. 2017 Nov;5(11):881-890. doi: 10.1016/S2213-2600(17)30306-5. Epub 2017 Oct 3. Lancet Respir Med. 2017. PMID: 28986128 Free PMC article. Review. - Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials.
Jolliffe DA, Camargo CA Jr, Sluyter JD, Aglipay M, Aloia JF, Ganmaa D, Bergman P, Borzutzky A, Damsgaard CT, Dubnov-Raz G, Esposito S, Gilham C, Ginde AA, Golan-Tripto I, Goodall EC, Grant CC, Griffiths CJ, Hibbs AM, Janssens W, Khadilkar AV, Laaksi I, Lee MT, Loeb M, Maguire JL, Majak P, Mauger DT, Manaseki-Holland S, Murdoch DR, Nakashima A, Neale RE, Pham H, Rake C, Rees JR, Rosendahl J, Scragg R, Shah D, Shimizu Y, Simpson-Yap S, Kumar GT, Urashima M, Martineau AR. Jolliffe DA, et al. medRxiv [Preprint]. 2020 Nov 25:2020.07.14.20152728. doi: 10.1101/2020.07.14.20152728. medRxiv. 2020. PMID: 33269357 Free PMC article. Updated. Preprint. - Vitamin D and Respiratory Tract Infections: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Bergman P, Lindh AU, Björkhem-Bergman L, Lindh JD. Bergman P, et al. PLoS One. 2013 Jun 19;8(6):e65835. doi: 10.1371/journal.pone.0065835. Print 2013. PLoS One. 2013. PMID: 23840373 Free PMC article. Review.
Cited by
- Retrospective Analysis of the Effect of Postmenopausal Women Medications on SARS-CoV-2 Infection Progression.
Cocetta V, Zorzi M, Bejor S, Cesta MC, De Pizzol M, Theurillat JP, Allegretti M, Alimonti A, Montopoli M, Rugge M. Cocetta V, et al. Life (Basel). 2024 Sep 3;14(9):1107. doi: 10.3390/life14091107. Life (Basel). 2024. PMID: 39337891 Free PMC article. - Vitamin D for the management of chronic obstructive pulmonary disease.
Williamson A, Martineau AR, Jolliffe D, Sheikh A, Janssens W, Sluyter J, Rafiq R, de Jongh R, Griffiths CJ. Williamson A, et al. Cochrane Database Syst Rev. 2024 Sep 27;9(9):CD013284. doi: 10.1002/14651858.CD013284.pub2. Cochrane Database Syst Rev. 2024. PMID: 39329240 Review. - Role of vitamin D in COVID-19 and other viral infections.
Engin MMN, Özdemir Ö. Engin MMN, et al. World J Virol. 2024 Sep 25;13(3):95349. doi: 10.5501/wjv.v13.i3.95349. World J Virol. 2024. PMID: 39323448 Free PMC article. Review. - Identifying the Risk Factors of Adverse Pregnancy Outcomes among Women with COVID-19: A Population-Based Case-Control Study in Southern Iran.
Soltani S, Mobarakabadi A, Hosseinpour Kohshahi M, Banaei M, Taheri M, Dashti S, Hosseini Teshnizi S, Roozbeh N. Soltani S, et al. J Caring Sci. 2024 Apr 13;13(2):106-115. doi: 10.34172/jcs.33156. eCollection 2024 Jul. J Caring Sci. 2024. PMID: 39318730 Free PMC article. - Effects of Vitamin D Supplementation and Baseline Vitamin D Status on Acute Respiratory Infections and Cathelicidin: A Randomized Controlled Trial.
Laaksi A, Kyröläinen H, Pihlajamäki H, Vaara JP, Luukkaala T, Laaksi I. Laaksi A, et al. Open Forum Infect Dis. 2024 Aug 27;11(9):ofae482. doi: 10.1093/ofid/ofae482. eCollection 2024 Sep. Open Forum Infect Dis. 2024. PMID: 39301110 Free PMC article. Clinical Trial.
References
- Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA 2009;302:758-66. 10.1001/jama.2009.1163 pmid:19690308. - DOI - PMC - PubMed
- GBD 2013 Mortality and Causes of Death Collaborators. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 2015;385:117-71. 10.1016/S0140-6736(14)61682-2 pmid:25530442. - DOI - PMC - PubMed
- Cannell JJ, Vieth R, Umhau JC, et al. Epidemic influenza and vitamin D. Epidemiol Infect 2006;134:1129-40. 10.1017/S0950268806007175 pmid:16959053. - DOI - PMC - PubMed
- Jolliffe DA, Griffiths CJ, Martineau AR. Vitamin D in the prevention of acute respiratory infection: systematic review of clinical studies. J Steroid Biochem Mol Biol 2013;136:321-9. 10.1016/j.jsbmb.2012.11.017 pmid:23220552. - DOI - PubMed
- Hansdottir S, Monick MM, Hinde SL, Lovan N, Look DC, Hunninghake GW. Respiratory epithelial cells convert inactive vitamin D to its active form: potential effects on host defense. J Immunol 2008;181:7090-9. 10.4049/jimmunol.181.10.7090 pmid:18981129. - DOI - PMC - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- HTA/13/03/25/DH_/Department of Health/United Kingdom
- G1000758/MRC_/Medical Research Council/United Kingdom
- U10 HL064313/HL/NHLBI NIH HHS/United States
- U10 HL098115/HL/NHLBI NIH HHS/United States
- RP-PG-0407-10398/DH_/Department of Health/United Kingdom
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical